Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. RNAi - An Introduction

4. Industry Overview
     4.1 Recent Industry Activities
           4.1.1 US
           4.1.2 Europe
           4.1.3 Asia Pacific

5. RNAi Applications
     5.1 Therapeutics
     5.2 Drug Discovery & Development
     5.3 Agriculture

6. RNAi Technologies by Therapeutic Segment
     6.1 Oncology
     6.2 Ocular and Retinal Disorders
     6.3 Viral Infections
     6.4 Cardiac Diseases
     6.5 Neuronal and Behavioral Disorders
     6.6 Metabolic Syndrome

7. RNAi Technologies by Products and Tools
     7.1 RNAi Products
           7.1.1 RNAi Inhibitors
           7.1.2 RNAi Libraries
           7.1.3 RNAi Reagents
           7.1.4 RNAi Vectors
           7.1.5 RNAi Assays
           7.1.6 RNAi Controls
           7.1.7 RNAi Mimics
           7.2 RNAi Services

8. RNAi Technologies - Pipeline Analysis

9. Recent Industry Trends
     9.1 Research Focused on High-Throughput Target Discovery and Target Validation
     9.2 Strategic Activity Progressing for Consolidated Developments
     9.3 Companies Focusing on Systemic Delivery for RNAi
     9.4 Therapeutics: Most Promising Application for RNAi

10. Competitive Landscape
     10.1 Alnylam Pharmaceuticals
     10.2 Benitec Biopharma Ltd.
     10.3 Bioneer Corporation
     10.4 Calando Pharmaceuticals
     10.5 Dharmacon
     10.6 Galena Pharmaceuticals (RXi)
     10.7 Integrated DNA Technologies
     10.8 Isis Pharmaceuticals
     10.9 Life Technologies
     10.10 Merck (Sirna)
     10.11 Qiagen
     10.12 Quark Pharmaceuticals Inc
     10.13 Sigma Aldrich Corporation
     10.14 Silence Therapeutics
     10.15 Tekmira Pharmaceuticals